StocksMedium•13 November 2026•
1 min read
Towa Pharmaceutical Misses EPS Expectations by 75%
Key Facts
1Towa Pharmaceutical reported statutory earnings per share of JP¥25.60, missing analyst expectations by approximately 75%.
2Revenues were roughly in line with estimates at JP¥142b despite the significant earnings per share miss.
Towa Pharmaceutical reported statutory earnings per share of JP¥25.60, missing analyst expectations by approximately 75%. Simply Wall St reported that revenues were roughly in line with estimates at JP¥142b despite the significant earnings per share miss.
The earnings miss prompted analysts to downgrade future forecasts, with consensus now projecting revenues of JP¥305.4b by 2027. Despite the current bottom-line shortfall, analysts expect revenue growth to accelerate to 14% annually through the end of 2027, surpassing the company's historical growth rate of 12%.